These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9219489)

  • 21. Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria.
    Black K; Shea C; Dursun S; Kutcher S
    J Psychiatry Neurosci; 2000 May; 25(3):255-61. PubMed ID: 10863885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse events after the abrupt discontinuation of paroxetine.
    Dominguez RA; Goodnick PJ
    Pharmacotherapy; 1995; 15(6):778-80. PubMed ID: 8602387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Withdrawal reactions associated with venlafaxine.
    Parker G; Blennerhassett J
    Aust N Z J Psychiatry; 1998 Apr; 32(2):291-4. PubMed ID: 9588310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A possible explanation for dizziness following SSRI discontinuation.
    Smith PF; Darlington CL
    Acta Otolaryngol; 2010 Sep; 130(9):981-3. PubMed ID: 20144124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Withdrawal syndrome associated with abrupt discontinuation of SSRIs.
    Wincor MZ
    J Am Pharm Assoc (Wash); 1998; 38(4):500-1. PubMed ID: 9707961
    [No Abstract]   [Full Text] [Related]  

  • 26. Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system.
    Stahl MM; Lindquist M; Pettersson M; Edwards IR; Sanderson JH; Taylor NF; Fletcher AP; Schou JS
    Eur J Clin Pharmacol; 1997; 53(3-4):163-9. PubMed ID: 9476026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms.
    Sir A; D'Souza RF; Uguz S; George T; Vahip S; Hopwood M; Martin AJ; Lam W; Burt T
    J Clin Psychiatry; 2005 Oct; 66(10):1312-20. PubMed ID: 16259546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin reuptake inhibitor withdrawal.
    Coupland NJ; Bell CJ; Potokar JP
    J Clin Psychopharmacol; 1996 Oct; 16(5):356-62. PubMed ID: 8889907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic review and guide to selection of selective serotonin reuptake inhibitors.
    Edwards JG; Anderson I
    Drugs; 1999 Apr; 57(4):507-33. PubMed ID: 10235690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Withdrawal syndrome caused by selective serotonin reuptake inhibitors: apropos of a case].
    Bryois C; Rubin C; Zbinden JD; Baumann P
    Praxis (Bern 1994); 1998 Mar; 87(10):345-8. PubMed ID: 9545842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation.
    van Geffen EC; Hugtenburg JG; Heerdink ER; van Hulten RP; Egberts AC
    Eur J Clin Pharmacol; 2005 Jun; 61(4):303-7. PubMed ID: 15906018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of venlafaxine discontinuation symptoms with ondansetron.
    Raby WN
    J Clin Psychiatry; 1998 Nov; 59(11):621-2. PubMed ID: 9862610
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical management of antidepressant discontinuation.
    Rosenbaum JF; Zajecka J
    J Clin Psychiatry; 1997; 58 Suppl 7():37-40. PubMed ID: 9219493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SSRI discontinuation syndrome treated with fluoxetine.
    Benazzi F
    Int J Geriatr Psychiatry; 1998 Jun; 13(6):421-2. PubMed ID: 9658279
    [No Abstract]   [Full Text] [Related]  

  • 35. [Discontinuation of antidepressant serotonergic antidepressant].
    Andersen CL; Videbech P
    Ugeskr Laeger; 2010 Jan; 172(4):296-8. PubMed ID: 20105399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Venlafaxine and its discontinuation syndrome].
    Sierra Santos L; Raigal Martín Y; Ortega García A; Barriochoa Martínez de Pisón C; Aparicio Jabalquinto G
    Aten Primaria; 1999 Dec; 24(10):617-8. PubMed ID: 10659465
    [No Abstract]   [Full Text] [Related]  

  • 37. Venlafaxine withdrawal syndrome.
    Macbeth R; Rajagopalan M
    Aust N Z J Med; 1998 Apr; 28(2):218. PubMed ID: 9612536
    [No Abstract]   [Full Text] [Related]  

  • 38. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Development of (hypo)mania during discontinuation of venlafaxine in two patients with bipolar disorder].
    Tak LM; Stevens AW
    Tijdschr Psychiatr; 2013; 55(10):795-800. PubMed ID: 24166339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delirium Associated With Fluoxetine Discontinuation: A Case Report.
    Fan KY; Liu HC
    Clin Neuropharmacol; 2017; 40(3):152-153. PubMed ID: 28452902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.